The mutations in STK11 might have an impact on the tumor microenvironment by promoting the neutrophils, which can suppress T-cells, and increasing the markers, which can exhaust T-cells; therefore, the STK11 mutations might result in an immunologically ‘cold’ microenvironment, conferring resistance to ICIs [25, 27]. The gene discussed is STK11; the disease is neoplasm.